Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2541 (LINC02541) is a long non-coding RNA (lncRNA) located on chromosome 6 (chr6:113623535-113650074, negative strand) and consists of three exons[4]. It is classified as an intergenic lncRNA (lincRNA), meaning it does not overlap with protein-coding genes[3][4]. The transcript is non-coding by all major coding potential prediction metrics[4]. LINC02541 is expressed predominantly in keratinocytes and is downregulated upon interferon gamma (IFN-γ) stimulation, as well as in several inflammatory skin diseases such as psoriasis, atopic dermatitis, and Netherton syndrome, where its expression is negatively correlated with upregulation of the STAT3 gene[2]. Its likely function is regulatory, possibly influencing inflammatory signaling within the skin, but there is no direct evidence that it is currently a therapeutic target, nor are there known drugs or biomarkers associated with it[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2541 (LINC02541).